Investment Thesis
Astera Labs demonstrates exceptional fundamental strength with 115% revenue growth, 363% net income growth, and best-in-class profitability metrics (75.7% gross margin, 25.7% net margin). The company maintains fortress-like balance sheet health with zero debt, massive liquidity (10.24x current ratio), and strong free cash flow conversion (33.1% FCF margin), indicating sustainable growth momentum in the semiconductor sector.
ALAB Strengths
- Explosive revenue growth of 115% YoY with 363% net income acceleration demonstrates exceptional business momentum and operating leverage
- Industry-leading gross margin of 75.7% and net margin of 25.7% indicate strong pricing power and operational efficiency in semiconductor manufacturing
- Fortress balance sheet with $1.4B equity, zero long-term debt, $167.6M cash, and 10.24x current ratio provides substantial financial flexibility
- Exceptional free cash flow generation of $281.8M (33.1% of revenue) demonstrates high-quality earnings and capital-efficient operations
- Strong returns on equity (16.1%) and assets (14.3%) indicate efficient capital deployment and shareholder value creation
ALAB Risks
- Rapid growth of 115% YoY may not be sustainable long-term; semiconductor market cyclicality could pressure future revenue expansion
- High insider activity with 13 Form 4 filings in 90 days warrants monitoring for potential lock-up expirations or dilutive equity issuances
- Concentrated customer base typical in semiconductor industry creates revenue concentration risk that is not disclosed in provided metrics
- Capital expenditure requirements may increase significantly to support growth, potentially impacting free cash flow conversion rates
Key Metrics to Watch
- Quarterly revenue growth sustainability relative to 115% YoY baseline
- Gross margin maintenance above 75% as product mix evolves
- Free cash flow conversion to ensure earnings quality remains intact
- Customer concentration and diversification trends
- Capital expenditure trajectory and return on invested capital
ALAB Financial Metrics
ALAB Profitability Ratios
ALAB Balance Sheet & Liquidity
ALAB 5-Year Financial Trend
5-Year Trend Summary: Astera Labs, Inc.'s revenue has grown significantly by 115% over the 5-year period, indicating strong business expansion. The most recent EPS of $-0.71 indicates the company is currently unprofitable.
ALAB Growth Metrics (YoY)
ALAB Quarterly Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2025 | $113.1M | -$7.6M | $-0.05 |
| Q2 2025 | $76.9M | -$7.5M | $-0.05 |
| Q1 2025 | $65.3M | $31.8M | $0.18 |
| Q3 2024 | $36.9M | -$3.1M | $-0.05 |
| Q2 2024 | $10.7M | -$7.5M | $-0.05 |
| Q1 2024 | $17.7M | -$17.5M | $-0.49 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
ALAB Capital Allocation
ALAB SEC Filings
Access official SEC EDGAR filings for Astera Labs, Inc. (CIK: 0001736297)